Prostate Specific Antigen, Mean Platelet Volume, and Platelet Distribution Width in Combination to Discriminate Prostate Cancer from Benign Prostate Hyperplasia

BACKGROUND: Prostate cancer (PCa) represents the second most commonly diagnosed malignancy and the sixth leading cause for cancer related death among men worldwide. Although use of the prostate specific antigen (PSA) as a diagnostic marker has improved the detection and management of PCa, low specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Shuang, Zhang, Xin, Niu, Ye, Wang, Rui-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980844/
https://www.ncbi.nlm.nih.gov/pubmed/29580043
http://dx.doi.org/10.22034/APJCP.2018.19.3.699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980844/
https://www.ncbi.nlm.nih.gov/pubmed/29580043
http://dx.doi.org/10.22034/APJCP.2018.19.3.699

Ejemplares similares